Is HDGHF or MRK a better dividend investment in 2026?

HDGHF currently yields 68965.52% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: HDGHF offers higher current income.

What is the dividend yield difference between HDGHF and MRK?

HDGHF has a forward dividend yield of 68965.52% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 68962.76 percentage points.

Home › Compare › HDGHF vs MRK

HDGHF vs MRK: Dividend Comparison 2026

HDGHF yields 68965.52% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HDGHF wins by $1.1839933886478554e+25M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HDGHF

● Live price

68965.52%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.1839933886478554e+25M

Annual income

$11,806,258,076,409,250,000,000,000,000,000.00

Full HDGHF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — HDGHF vs MRK

📍 HDGHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HDGHF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HDGHF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HDGHF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HDGHF

Annual income on $10K today (after 15% tax)

$5,862,068.97/yr

After 10yr DRIP, annual income (after tax)

$10,035,319,364,947,863,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, HDGHF beats the other by $10,035,319,364,947,863,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HDGHF + MRK for your $10,000?

HDGHF: 50%MRK: 50%

100% MRK50/50100% HDGHF

Portfolio after 10yr

$5.919966943239277e+24M

Annual income

$5,903,129,038,204,625,000,000,000,000,000.00/yr

Blended yield

99.72%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HDGHF

No analyst data

Altman Z

-19.8

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HDGHF buys

MRK buys

No recent congressional trades found for HDGHF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHDGHFMRK

Forward yield	68965.52% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$1.1839933886478554e+25M	$56.8K ✓
Annual income after 10y	$11,806,258,076,409,250,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$1.1837725309237889e+25M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HDGHF vs MRK ($10,000, DRIP)

Year	HDGHF Portfolio	HDGHF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$6,907,252	$6,896,551.72	$11,206	$366.19	+$6.90M → HDGHF
2	$4,459,373,824	$4,451,983,064.22	$12,650	$502.35	+$4459.36M → HDGHF
3	$2,690,971,392,991	$2,686,199,862,999.76	$14,407	$694.19	+$2690971.38M → HDGHF
4	$1,517,799,501,371,570	$1,514,920,161,981,069.00	$16,585	$967.82	+$1517799501.35M → HDGHF
5	$800,190,923,014,392,800	$798,566,877,547,925,100.00	$19,342	$1,363.89	+$800190923014.37M → HDGHF
6	$394,321,769,154,895,900,000	$393,465,564,867,270,500,000.00	$22,913	$1,947.19	+$394321769154895.88M → HDGHF
7	$181,631,058,470,881,800,000,000	$181,209,134,177,886,080,000,000.00	$27,662	$2,823.89	+$181631058470881792.00M → HDGHF
8	$78,201,720,943,575,400,000,000,000	$78,007,375,711,011,540,000,000,000.00	$34,159	$4,173.35	+$78201720943575400448.00M → HDGHF
9	$31,472,719,690,937,434,000,000,000,000	$31,389,043,849,527,810,000,000,000,000.00	$43,337	$6,308.80	+$3.1472719690937433e+22M → HDGHF
10	$11,839,933,886,478,554,000,000,000,000,000	$11,806,258,076,409,250,000,000,000,000,000.00	$56,776	$9,798.13	+$1.1839933886478554e+25M → HDGHF

HDGHF vs MRK: Complete Analysis 2026

HDGHF — Stock

Haydale Graphene Industries plc, through its subsidiaries, produces, sells, and functionalizes graphene and other nanomaterials in the United Kingdom, Europe, the United States, China, Thailand, South Korea, Japan, and internationally. It offers inks and coatings, resins, and fluids and masterbatches for use in composites and polymers; masterbatch and pre-preg composites, elastomers and other nanomaterials; and installed SiC. In addition, it provides graphene face masks; ceramycGuard; composites; elastomers; silicon carbide whiskers; and advanced consulting and test services. The company serves the aerospace, automotive, marine, medical, printing inks and coating, and sports industries. Haydale Graphene Industries plc was formerly known as Innovative Carbon Limited and changed its name to Haydale Graphene Industries plc in March 2014. The company was incorporated in 2010 and is headquartered in Ammanford, the United Kingdom.

Full HDGHF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this HDGHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HDGHF vs SCHD HDGHF vs JEPI HDGHF vs O HDGHF vs KO HDGHF vs MAIN HDGHF vs JNJ HDGHF vs ABBV HDGHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.